Poland: 2,000+ patients wait up to 623 days for specialty drug programs

As of June, over 2,000 patients in Poland were on waiting lists for eight drug programs in gastroenterology, dermatology, and rheumatology, with extreme waits approaching two years. Patient organizations are demanding changes in financing and organization, highlighting systemic access failures. The development underscores chronic underfunding and inefficiency in Poland's specialized care, though no immediate policy shift is indicated.